{"database": "lobbying", "table": "lobbying_activities", "rows": [[1628084, "08775d50-846b-4794-a047-d4fd98aef239", "Q4", "SHIRE PHARMACEUTICALS LLC", 323477, "SHIRE PHARMACEUTICALS LLC", 2014, "fourth_quarter", "PHA", "issues surrounding ADHD, including economic and social impact;\nbinge eating disorder;\ndrug shortages;\nDEA processes;\nFDA funding and sequester;\nspecialty tiers;\ntrack and trace;\nstep therapy;\ndrug development;\npatent issues;\nH.R. 5805, Andrea Sloan Compassionate Use Reform and Enhancement Act, relating to expanded access;\nH.R. 1281, Newborn Screening Saves Lives Reauthorization Act of 2014;\nPriority Review Vouchers;\nFDASIA implementation;\nACA implementation;\nbundling rules for the Hospital Outpatient Prospective Payment System;\nCMS coding coverage;\nline extension rebates;\nMedicare Part D rebates;\nH.J. Res. 59, Continuing Appropriations Resolution, 2014 and possible drug industry issues;\ntax reform;\norphan drug tax credit;\nR&D tax credits", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 380000, 0, 0, "2015-01-18T14:23:31.687000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1628084"], "units": {}, "query_ms": 20.191670977510512, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}